Example: tourism industry
Organisation Chart - European Medicines Agency
Classified as public by the European Medicines Agency Scientific Evidence Generation Department Quality and Safety of Medicines Department Committees
Tags:
Information
Domain:
Source:
Link to this page:
Documents from same domain
European Medicines Agency
www.ema.europa.eu© EMEA 2006 2 SPECIFICATIONS: TEST PROCEDURES AND ACCEPTANCE CRITERIA FOR BIOTECHNOLOGICAL/BIOLOGICAL PRODUCTS ICH Harmonised Tripartite Guideline
Q12 Step 2b Technical and regulatory …
www.ema.europa.euICH guideline Q12 on technical and regulatory considerations for pharmaceutical product lifecycle management EMA/CHMP/ICH/804273/2017 Page 3/36
Guideline on good pharmacovigilance practices …
www.ema.europa.eu9 December 2013 . EMA/816292/2011 Rev 1* Guideline on good pharmacovigilance practices (GVP) Module VII – Periodic safety update report (Rev 1)
Guideline on good pharmacovigilance practices (GVP)
www.ema.europa.euGuideline on good pharmacovigilance practices (GVP) – Module IX (Rev 1) EMA/827661/2011 Rev 1 Page 2/25
Guideline on good pharmacovigilance practices …
www.ema.europa.euGuideline on good pharmacovigilance practices (GVP) – Module VIII (Rev 3) EMA/813938/2011 Rev 3 Page 2/28
Guideline for good clinical practice E6(R2)
www.ema.europa.euGuideline for good clinical practice E6(R2) EMA/CHMP/ICH/135/1995 Page 2/70 Document History First Codification History Date New Codification
Guideline for good clinical practice E6(R2)
www.ema.europa.euGuideline for good clinical practice E6(R2) EMA/CHMP/ICH/135/1995 Page 2/75 10 Document History 11 First Codification History Date New Codification November
Guideline on good pharmacovigilance practices …
www.ema.europa.euharmful physical or psychological effects [DIR 2001/83/EC Art 1(1 6)]. 74 Adverse event (AE); synonym: Adverse experience 75 Any untoward medical occurrence in a patient or clinical- trial subject administered a medicinal product
products1/traditional herbal medicinal products
www.ema.europa.euThere is no expectation that existing herbal medicinal products on the market will be affected by this guideline, with the exception of traditional herbal medicinal products for human use that were already
Q7 Q&A - good manufacturing practice for active ...
www.ema.europa.euICH guideline Q7 on good manufacturing practice for active pharmaceutical ingredients – questions and answers EMA/CHMP/ICH/468930/2015 Page 2/37
Related documents
The European regulatory system for medicines
www.ema.europa.euhow the European medicines regulatory network—a partnership between the European Commission, the medicines regulatory authorities in EU Member States and the European Economic Area (EEA), and the European Medicines Agency (EMA)—works to ensure that patients in the EU have access to high-quality, effective and safe medicines.
WHO Model List of Essential Medicines
www.who.int16th edition (updated) Essential Medicines WHO Model List (March 2010) Explanatory Notes The core list presents a list of minimum medicine needs for a basic health‐care system, listing the most efficacious, safe and cost‐effective medicines for priority conditions.
How to Dispose of Medicines Properly - US EPA
archive.epa.govKeeps medicines from entering streams and rivers when poured down the drain or flushed down the toilet In homes that use septic tanks, prescription and over-the-counter drugs flushed down the toilet can leach into the ground and seep into ground water.
The Good Sleep Guide - Health Service Executive
www.hse.ieAdapted with the kind permission of the All Wales Medicines Strategy Group Educational Pack: Material to Support Appropriate Prescribing of Hypnotics and Anxiolytics across Wales. Other Practical Tips - Avoid using smart phones or other devices which emit ‘blue light’ late in the evening/night as this can disrupt normal sleep schedules.
Medicines for the Prevention of Malaria While Traveling ...
www.cdc.govMedicines for the Prevention of Malaria While Traveling Atovaquone-Proguanil (Malarone™) What is atovaquone-proguanil? Atovaquone-proguanil is a combination of two drugs, atovaquone and proguanil, in a single tablet. It is . available in the United States by prescription only. It is sold under the brand name Malarone and it is also sold
Medicines for COPD - American Thoracic Society
www.thoracic.orgMost medicines have two names, a generic and a brand name. The generic name describes the main chemical in the drug. The brand name is decided by the maker (or makers) of the medicine. If several companies make the same generic drug, then the drug may be known by several brand names. Names may vary by country.